Symbols

SSKN

STRATA Skin Sciences·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 2

Bearish signal 1

High Gross Profit Margin

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SSKN

Strata Skin Sciences, Inc.

A company that developing a non-invasive, point-of-care system to assist in the detection of early melanoma

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

10/31/2005

Exchange

NASDAQ Stock Exchange

Full-time Employees

106

Fiscal Year Ends

12-31

Website

www.strataskinsciences.com

Security Type

Common stock

Office address

5 Walnut Grove Drive, Suite 140 Horsham, Pennsylvania 19044

Business

Introduction

STRATA Skin Sciences, Inc., commenced operations as a New York corporation in December 1989 and was re-incorporated as a Delaware corporation in September 1997. The company is a dermatological medical technology company that develops, commercializes and markets innovative products for the treatment of skin diseases. The company's products include XTRAC and now Pharos excimer lasers and VTRAC light systems for the treatment of psoriasis, vitiligo and various skin conditions. The company's products also include the TheraClear Acne Treatment System for the treatment of mild to moderate inflammatory, acne and pustular acne.

Earnings Call

Q3/2025

Estimate EPS-0.24

Actual EPS-0.36

Estimate Revenue7.72M

Actual Revenue6.93M

STRATA's Q3 2025 Earnings Call: Conflicting Guidance on Average Revenue per Device, Elevate 360 Growth, and Installed Base Numbers Raise Red Flags for Investors

Nov 13,2025 08:38·
Earnings Decrypt

Company Financials

EPS

SSKN has released its 2025 Q3 earnings. EPS was reported at -0.36, versus the expected -0.24, missing expectations. The chart below visualizes how SSKN has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SSKN has released its 2025 Q3 earnings report, with revenue of 6.93M, reflecting a YoY change of -21.23%, and net profit of -1.62M, showing a YoY change of 21.79%. The Sankey diagram below clearly presents SSKN's revenue sources and cost distribution.